Isofol completes recruitment of Japanese patients in the global phase III AGENT study ...Middle East

PR Newswire - News
GOTHENBURG, Sweden, May 6, 2021 /PRNewswire/ -- In December 2020, Isofol Medical AB (publ) ("Isofol"), (Nasdaq First North Premier Growth Market: ISOFOL) reached its primary recruitment objective with the recruitment of 440 patients in the global phase III AGENT study. Today the company...

Hence then, the article about isofol completes recruitment of japanese patients in the global phase iii agent study was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Isofol completes recruitment of Japanese patients in the global phase III AGENT study )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News